High-performance liquid chromatographic analysis of the antitumour drug camptothecin and its lactone ring-opened form in rat plasma

J Chromatogr. 1993 Jul 23;617(1):111-7. doi: 10.1016/0378-4347(93)80428-7.

Abstract

A sensitive high-performance liquid chromatographic (HPLC) method is described for the simultaneous determination of the antitumour drug camptothecin (I) and its lactone ring-opened form (II) in plasma. The sample pretreatment involved protein precipitation with cold methanol (-30 degrees C). The methanolic extract was injected directly onto the HPLC column. Chromatography was carried out with a LiChrosorb RP-18 column (particle size 5 microns) and a mobile phase composed of methanol-phosphate buffer (5 mM, pH 6.5)-0.3 M tetrabutylammonium phosphate solution (500:500:15, v/v/v). The column effluent was monitored spectrofluorimetrically with the excitation wavelength set at 369 nm and the emission wavelength at 426 nm. The chemical stabilities of camptothecin and the ring-opened form in aqueous solutions, in plasma and after methanolic extraction, were investigated. The proposed method was validated and utilized in pharmacokinetic studies with rats.

MeSH terms

  • Animals
  • Camptothecin / blood*
  • Camptothecin / chemistry
  • Camptothecin / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Lactones / blood*
  • Lactones / chemistry
  • Lactones / pharmacokinetics
  • Rats
  • Reproducibility of Results
  • Spectrometry, Fluorescence

Substances

  • Lactones
  • Camptothecin